|
Allopurinol 300 MG Clinical Trials
2 actively recruiting trials across 1 location
▲ +1 trial since August 2026
Pipeline
Phase 2: 1Phase 2/3: 1
Top Sponsors
- Tanta University1
- Masonic Cancer Center, University of Minnesota1
Indications
- Depression1
- Myelofibrosis1
- Relapsed Chronic Lymphocytic Leukemia1
- Relapsed T-Cell Lymphoma1
- Prolymphocytic Leukemia1
Other1 trial
Phase 2/3
Minneapolis, Minnesota1 trial
Allo HSCT Using RIC and PTCy for Hematological Diseases
Masonic Cancer Center at University of Minnesota
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.